BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26413812)

  • 21. Protein tyrosine phosphatase receptor type γ is a JAK phosphatase and negatively regulates leukocyte integrin activation.
    Mirenda M; Toffali L; Montresor A; Scardoni G; Sorio C; Laudanna C
    J Immunol; 2015 Mar; 194(5):2168-79. PubMed ID: 25624455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
    Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
    J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease.
    Barretina J; Juncà J; Llano A; Gutiérrez A; Flores A; Blanco J; Clotet B; Esté JA
    Ann Hematol; 2003 Aug; 82(8):500-505. PubMed ID: 12783211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia.
    de Rooij MF; Kuil A; Geest CR; Eldering E; Chang BY; Buggy JJ; Pals ST; Spaargaren M
    Blood; 2012 Mar; 119(11):2590-4. PubMed ID: 22279054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.
    Haerzschel A; Catusse J; Hutterer E; Paunovic M; Zirlik K; Eibel H; Krenn PW; Hartmann TN; Burger M
    Ann Hematol; 2016 Dec; 95(12):1979-1988. PubMed ID: 27542958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell motility in chronic lymphocytic leukemia: defective Rap1 and alphaLbeta2 activation by chemokine.
    Till KJ; Harris RJ; Linford A; Spiller DG; Zuzel M; Cawley JC
    Cancer Res; 2008 Oct; 68(20):8429-36. PubMed ID: 18922916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells.
    Rozovski U; Wu JY; Harris DM; Liu Z; Li P; Hazan-Halevy I; Ferrajoli A; Burger JA; O'Brien S; Jain N; Verstovsek S; Wierda WG; Keating MJ; Estrov Z
    Blood; 2014 Jun; 123(24):3797-802. PubMed ID: 24778152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H-Ras signals to cytoskeletal machinery in induction of integrin-mediated adhesion of T cells.
    Tanaka Y; Minami Y; Mine S; Hirano H; Hu CD; Fujimoto H; Fujii K; Saito K; Tsukada J; van Kooyk Y; Figdor CG; Kataoka T; Eto S
    J Immunol; 1999 Dec; 163(11):6209-16. PubMed ID: 10570313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.
    Vaisitti T; Aydin S; Rossi D; Cottino F; Bergui L; D'Arena G; Bonello L; Horenstein AL; Brennan P; Pepper C; Gaidano G; Malavasi F; Deaglio S
    Leukemia; 2010 May; 24(5):958-69. PubMed ID: 20220774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of chemokines and their receptors in chronic lymphocytic leukemia: function in microenvironment and targeted therapy.
    Han TT; Fan L; Li JY; Xu W
    Cancer Biol Ther; 2014 Jan; 15(1):3-9. PubMed ID: 24149438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a.
    Ticchioni M; Essafi M; Jeandel PY; Davi F; Cassuto JP; Deckert M; Bernard A
    Oncogene; 2007 Nov; 26(50):7081-91. PubMed ID: 17496928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium.
    Till KJ; Spiller DG; Harris RJ; Chen H; Zuzel M; Cawley JC
    Blood; 2005 Jun; 105(12):4813-9. PubMed ID: 15731179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.
    Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M
    Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma.
    Plander M; Ugocsai P; Seegers S; Orsó E; Reichle A; Schmitz G; Hofstädter F; Brockhoff G
    Ann Hematol; 2011 Dec; 90(12):1381-90. PubMed ID: 21465189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.
    Benkisser-Petersen M; Buchner M; Dörffel A; Dühren-von-Minden M; Claus R; Kläsener K; Leberecht K; Burger M; Dierks C; Jumaa H; Malavasi F; Reth M; Veelken H; Duyster J; Zirlik K
    PLoS One; 2016; 11(12):e0169159. PubMed ID: 28036404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation.
    Edelmann B; Gupta N; Schnoeder TM; Oelschlegel AM; Shahzad K; Goldschmidt J; Philipsen L; Weinert S; Ghosh A; Saalfeld FC; Nimmagadda SC; Müller P; Braun-Dullaeus R; Mohr J; Wolleschak D; Kliche S; Amthauer H; Heidel FH; Schraven B; Isermann B; Müller AJ; Fischer T
    J Clin Invest; 2018 Oct; 128(10):4359-4371. PubMed ID: 30024857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia.
    Giannoni P; Cutrona G; Totero D
    Curr Mol Med; 2017; 17(1):24-33. PubMed ID: 28231754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells.
    Glodek AM; Le Y; Dykxhoorn DM; Park SY; Mostoslavsky G; Mulligan R; Lieberman J; Beggs HE; Honczarenko M; Silberstein LE
    Leukemia; 2007 Aug; 21(8):1723-32. PubMed ID: 17568820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease.
    Vlad A; Deglesne PA; Letestu R; Saint-Georges S; Chevallier N; Baran-Marszak F; Varin-Blank N; Ajchenbaum-Cymbalista F; Ledoux D
    Cancer Res; 2009 Aug; 69(16):6387-95. PubMed ID: 19654311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406.
    Borge M; Remes Lenicov F; Nannini PR; de los Ríos Alicandú MM; Podaza E; Ceballos A; Fernández Grecco H; Cabrejo M; Bezares RF; Morande PE; Oppezzo P; Giordano M; Gamberale R
    J Immunol; 2014 Sep; 193(6):3165-74. PubMed ID: 25127862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.